Stavudine
- Generic Name
- Stavudine
- Brand Names
- Zerit
- Drug Type
- Small Molecule
- Chemical Formula
- C10H12N2O4
- CAS Number
- 3056-17-5
- Unique Ingredient Identifier
- BO9LE4QFZF
Overview
A dideoxynucleoside analog that inhibits reverse transcriptase and has in vitro activity against HIV.
Background
A dideoxynucleoside analog that inhibits reverse transcriptase and has in vitro activity against HIV.
Indication
For the treatment of human immunovirus (HIV) infections.
Associated Conditions
- Human Immunodeficiency Virus (HIV) Infections
Clinical Trials
FDA Approved Products
Stavudine
Manufacturer:State of Florida DOH Central Pharmacy
Route:ORAL
Strength:40 mg in 1 1
Approved: 2010/06/08
NDC:53808-0595
stavudine
Manufacturer:Cipla Ltd.
Route:ORAL
Strength:1 mg in 1 mL
Approved: 2019/01/16
NDC:53104-0111
ZERIT
Manufacturer:State of Florida DOH Central Pharmacy
Route:ORAL
Strength:20 mg in 1 1
Approved: 2010/08/12
NDC:53808-0656
ZERIT
Manufacturer:State of Florida DOH Central Pharmacy
Route:ORAL
Strength:40 mg in 1 1
Approved: 2010/08/12
NDC:53808-0795
ZERIT
Manufacturer:State of Florida DOH Central Pharmacy
Route:ORAL
Strength:30 mg in 1 1
Approved: 2010/08/12
NDC:53808-0657
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath